150 related articles for article (PubMed ID: 34275318)
1. The value of immunohistochemical methods in diagnosing mesenchymal tumours of the uterus.
Dundr P; Gregová M; Němejcová K; Bártů M; Bennett RJ; Stružinská I
Cesk Patol; 2021; 57(2):86-95. PubMed ID: 34275318
[TBL] [Abstract][Full Text] [Related]
2. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
[TBL] [Abstract][Full Text] [Related]
3. Breast metastasis in high-grade endometrial stromal sarcoma (HG-ESS) with BCOR rearrangement: a case report of a novel metastatic site.
Fong A; Offman S
Diagn Pathol; 2023 Mar; 18(1):34. PubMed ID: 36864468
[TBL] [Abstract][Full Text] [Related]
4. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
Croce S; Devouassoux-Shisheboran M; Pautier P; Ray-Coquard I; Treilleux I; Neuville A; Arnould L; Just PA; Le Frere Belda MA; Averous G; Leroux A; Bataillon G; Mery E; Loussouarn D; Weinbreck N; Le Guellec S; Mishellany F; Morice P; Guyon F; Genestie C
Bull Cancer; 2024 Jan; 111(1):97-116. PubMed ID: 37806863
[TBL] [Abstract][Full Text] [Related]
6. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
[TBL] [Abstract][Full Text] [Related]
7. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
Moura MS; Costa J; Velasco V; Kommoss F; Oliva E; Le Loarer F; McCluggage WG; Razack R; Treilleux I; Mills A; Longacre T; Devouassoux-Shisheboran M; Hostein I; Azmani R; Blanchard L; Hartog C; Soubeyran I; Khalifa E; Croce S
Histopathology; 2024 Feb; 84(3):451-462. PubMed ID: 37988282
[TBL] [Abstract][Full Text] [Related]
8. Uterine mesenchymal tumours: recent advances.
Momeni-Boroujeni A; Chiang S
Histopathology; 2020 Jan; 76(1):64-75. PubMed ID: 31846533
[TBL] [Abstract][Full Text] [Related]
9. Endometrial stromal sarcomas with unusual histologic features: a report of 24 primary and metastatic tumors emphasizing fibroblastic and smooth muscle differentiation.
Yilmaz A; Rush DS; Soslow RA
Am J Surg Pathol; 2002 Sep; 26(9):1142-50. PubMed ID: 12218570
[TBL] [Abstract][Full Text] [Related]
10. Update on Endometrial Stromal Tumours of the Uterus.
Akaev I; Yeoh CC; Rahimi S
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33802452
[TBL] [Abstract][Full Text] [Related]
11. [Values of JAZF1 gene rearrangement detected by fluorescence in-situ hybridization in diagnosis of endometrial stromal tumours].
Bai QM; Chang B; Tu XY; Bi R; Cheng YF; Huang D; Zhu XL; Wu LJ; Zhang X; Zhou XY; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):769-774. PubMed ID: 29136690
[No Abstract] [Full Text] [Related]
12. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.
Hoang L; Chiang S; Lee CH
Pathology; 2018 Feb; 50(2):162-177. PubMed ID: 29275929
[TBL] [Abstract][Full Text] [Related]
13. [Endometrial stromal sarcoma: morphologic features and detection of JAZF1-SUZ12 and YWHAE FAM22 fusion genes].
Chang B; Lu LX; Tu XY; Cheng YF; Bi R; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):308-13. PubMed ID: 27142911
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
[TBL] [Abstract][Full Text] [Related]
15. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
[TBL] [Abstract][Full Text] [Related]
16. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
[TBL] [Abstract][Full Text] [Related]
17. High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies.
Kim Y; Kim D; Sung WJ; Hong J
Front Immunol; 2022; 13():837004. PubMed ID: 35242139
[TBL] [Abstract][Full Text] [Related]
18. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms.
McCluggage WG; Sumathi VP; Maxwell P
Histopathology; 2001 Sep; 39(3):273-8. PubMed ID: 11532038
[TBL] [Abstract][Full Text] [Related]
19. Endometrial stromal tumors: the new WHO classification.
Conklin CM; Longacre TA
Adv Anat Pathol; 2014 Nov; 21(6):383-93. PubMed ID: 25299308
[TBL] [Abstract][Full Text] [Related]
20. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
Lax SF
Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
